Streetbeat News

Stock Prices

ELTK

Eltek shares are trading lower following the announcement of disappointing Q4 financial results, which fell below market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 3:03 pm

NEARUSD

NEAR Protocol (CRYPTO: NEAR) has seen a significant increase of 18.14% in its price over the last 24 hours, reaching $7.02. This surge is part of a larger trend, with a 57.0% gain over the past week from $4.46. Despite this growth, it remains below its all-time high of $20.44. The trading volume for NEAR has increased by 109.0% in the same period, while its circulating supply has slightly decreased by 0.59%, now standing at 1.04 billion. NEAR's market cap ranks it 21st at $7.26 billion.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 3:02 pm

BTAI

BioXcel Therapeutics (NASDAQ:BTAI) is scheduled to release its quarterly earnings report on March 12, 2024, with an expected EPS of $-0.91. Despite past earnings misses, the company's stock price has shown mixed reactions, with a significant 85.15% decline over the last year. Investors are keen on the upcoming guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 3:02 pm

ENFN

Enfusion (NYSE:ENFN) is scheduled to release its quarterly earnings report on March 12, 2024, with an estimated EPS of $0.05. Historical performance shows mixed results with the last quarter missing estimates, leading to a 3.72% increase in share price the following day. Over the past year, ENFN shares have declined by 25.29%, indicating a bearish outlook among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 3:02 pm

GHLD

Guild Holdings (NYSE:GHLD) is scheduled to release its quarterly earnings report on March 12, 2024, with analysts expecting an EPS of $0.14. The company's past performance shows a pattern of beating EPS estimates, leading to positive stock price movements. Shares of GHLD have increased by 23.36% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 3:02 pm

DOTUSD

Polkadot's (CRYPTO: DOT) price increased by 6.15% in the last 24 hours, reaching $10.81, continuing a positive trend with a 6.0% gain over the past week from $10.18. Despite a 38.0% drop in trading volume, the circulating supply rose by 0.35% to 1.34 billion, with a current market cap ranking of #13 at $14.45 billion.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 3:02 pm

MXCT

MaxCyte (NASDAQ:MXCT) is scheduled to release its quarterly earnings report on March 12, 2024, with analysts expecting an EPS of $-0.07. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's miss resulting in a 3.28% drop. Shares are currently trading at $3.94, down 2.81% over the last year. Investors will be closely watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 3:02 pm

IGIC

Intl General Insurance (NASDAQ:IGIC) is scheduled to release its quarterly earnings report on March 12, 2024. Analysts predict an EPS of $0.71. The company's historical performance shows consistent earnings beats, with a notable 7.5% share price increase following last quarter's results. Shares have risen 55.56% over the past year, indicating positive sentiment among long-term investors.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 3:02 pm

DOMA

Doma Holdings (NYSE:DOMA) is scheduled to release its quarterly earnings report on March 12, 2024, with analysts expecting an EPS of $-1.30. Despite past earnings misses, the company's stock price has shown varied responses, including a 6.57% increase after last quarter's miss. Over the last year, DOMA shares have declined by 49.14%, reflecting investor concerns. The upcoming earnings and particularly the company's guidance will be crucial for investor sentiment.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 3:01 pm

SKIN

Beauty Health (NASDAQ:SKIN) is scheduled to release its quarterly earnings report on 2024-03-12, with analysts expecting an EPS of $-0.07. The company's past earnings performance shows a mix of misses and beats, with significant price changes following the announcements. Investors are particularly focused on the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 3:01 pm